1. Home
  2. PBH vs IRON Comparison

PBH vs IRON Comparison

Compare PBH & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prestige Consumer Healthcare Inc.

PBH

Prestige Consumer Healthcare Inc.

HOLD

Current Price

$56.72

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$66.34

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBH
IRON
Founded
1996
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.3B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
PBH
IRON
Price
$56.72
$66.34
Analyst Decision
Buy
Strong Buy
Analyst Count
3
11
Target Price
$75.33
$103.18
AVG Volume (30 Days)
520.1K
370.5K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
2.88
N/A
EPS
2.78
N/A
Revenue
$975,777,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.31
$283.52
P/E Ratio
$20.42
N/A
Revenue Growth
36.77
N/A
52 Week Low
$51.24
$38.80
52 Week High
$88.00
$99.50

Technical Indicators

Market Signals
Indicator
PBH
IRON
Relative Strength Index (RSI) 39.12 55.22
Support Level N/A $57.79
Resistance Level $63.56 $69.36
Average True Range (ATR) 2.30 2.73
MACD -0.12 0.97
Stochastic Oscillator 46.32 74.85

Price Performance

Historical Comparison
PBH
IRON

About PBH Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: